Assist. Prof. Dr. Dinesh Kumar | Nanobiotechnology | Global Nanotech Impact Award

Assistant Professor (Nano Science and Nano Technology), at Department of Interdisciplinary Sciences, National Institute of Food Technology Entrepreneurship and Management, Kundli, India.

Dr. Dinesh Kumar is a distinguished scientist with over 15 years of experience in the healthcare and biomedical research industry. His expertise spans various domains, including in-vitro diagnostics, food safety, molecular diagnostics, and quality control. He has made significant contributions to the development of rapid point-of-care diagnostic devices, biosensors, and immunoassays for infectious and non-communicable diseases. Dr. Kumar has a strong background in human research studies, epidemiology, biostatistics, and regulatory policies. He has been actively involved in accreditation processes for ISO 17025, ISO 15189, and ISO 13485 standards. His technical proficiency extends to software tools such as SPSS, Prism GraphPad, ChemDraw, and Sigma Plot, which he uses for data analysis and research. His work has been widely recognized, with multiple scientific publications, conference presentations, and collaborations with international regulatory bodies for CE marking and quality assurance. Passionate about innovation in healthcare, he has developed microfluidic test devices and IVD-grade recombinant proteins and antibodies. His research has significantly contributed to advancements in diagnostics, particularly in tuberculosis, antimicrobial resistance, and biomarker detection. Dr. Kumar continues to drive excellence in biomedical research through his technical expertise, innovative mindset, and dedication to improving global healthcare standards.

Professional Profile:

• Google Scholar

Education

Dr. Dinesh Kumar holds a Ph.D. in Biomedical Sciences from the prestigious Indian Institute of Technology (IIT) Delhi, where his doctoral research focused on developing immunoassays for detecting prednisolone using horseradish peroxidase and colloidal gold as labels. His research provided valuable insights into rapid, specific, and user-friendly diagnostic techniques. He also completed a Master of Science (M.Sc.) in Biochemistry from V M University, where he built a strong foundation in biochemical analysis and laboratory research. His undergraduate education includes a Bachelor of Science (B.Sc.) in Medical Laboratory Technology from V M University, equipping him with essential laboratory and clinical skills. Additionally, Dr. Kumar earned a Diploma in Medical Laboratory Technology (DMLT) from the Para Medical Board of India, further strengthening his expertise in clinical diagnostics. To expand his knowledge in food safety and quality management, he pursued a Postgraduate Diploma in Food Safety & Quality Management (PGDFSQM) from IGNOU, New Delhi. His multidisciplinary academic background has enabled him to integrate various scientific approaches into his research, particularly in molecular diagnostics and immunology. His educational journey reflects his commitment to continuous learning and his ability to bridge the gap between fundamental research and real-world healthcare applications.

Professional Experience

Dr. Dinesh Kumar has amassed extensive experience across multiple dimensions of the healthcare industry, including diagnostics research, quality control, and regulatory compliance. He has worked on mass-scale production and testing of in-vitro diagnostic (IVD) rapid kits, biochemistry kits, and RT-PCR molecular diagnostic kits. His expertise in diagnostics has played a crucial role in the development of innovative point-of-care testing devices. He has also provided technical support for product development in molecular diagnostics, biochemistry, and immunoassays, offering consultancy services to various healthcare organizations and government facilities. His experience in accreditation processes for ISO 17025 and ISO 15189 highlights his role in ensuring high-quality standards in laboratory testing. Dr. Kumar has also been actively involved in project preparation and implementation for government health facilities, focusing on improving diagnostic capabilities in healthcare institutions. His professional journey is marked by collaborations with international regulatory bodies, including those responsible for CE marking and ISO compliance. With a strong background in biostatistics and epidemiology, he has contributed significantly to the research and development of diagnostic tools for infectious diseases, antimicrobial resistance, and biomarkers for conditions such as cancer, cardiovascular diseases, and nephrology. His technical and managerial expertise makes him a leader in biomedical innovation.

Research Interests

Dr. Dinesh Kumar’s research interests lie at the intersection of biomedical diagnostics, molecular biology, and nanotechnology. He is particularly passionate about the development of rapid and cost-effective point-of-care diagnostic devices for communicable and non-communicable diseases. His work focuses on immunoassays, biosensors, microfluidic test devices, and molecular diagnostics, particularly RT-PCR technology for infectious disease detection. He has a keen interest in antimicrobial resistance research, aiming to develop diagnostic solutions that enable early detection and effective treatment of resistant infections. His expertise extends to the study of biomarkers for chronic diseases, including cancer, cardiovascular diseases, and nephrology. Additionally, Dr. Kumar has been actively involved in quality assurance and regulatory compliance for medical diagnostics, ensuring that innovations meet international standards for safety and efficacy. His research also encompasses bioinformatics and computational biology, utilizing advanced statistical and data analysis techniques to enhance diagnostic accuracy. His interest in nanotechnology is reflected in his work on biosensors and microfluidic platforms, which have the potential to revolutionize healthcare diagnostics. By integrating biotechnology, immunology, and analytical chemistry, Dr. Kumar strives to bridge the gap between research and clinical application, making diagnostic technologies more accessible and efficient for global healthcare systems.

Research Skills

Dr. Dinesh Kumar possesses a diverse range of research skills that make him a valuable asset in biomedical and healthcare research. He has expertise in immunoassay development, including enzyme-linked immunosorbent assay (ELISA) and lateral flow immunoassay (LFIA), which are crucial for rapid diagnostics. His technical skills in molecular diagnostics include RT-PCR, real-time PCR, and nucleic acid amplification techniques, making him proficient in detecting infectious diseases at the molecular level. He has extensive experience in biosensor technology, microfluidics, and point-of-care testing, particularly for tuberculosis, antimicrobial resistance, and biomarker detection. Dr. Kumar is also skilled in biostatistics and epidemiological data analysis, using software such as SPSS, Prism GraphPad, ChemDraw, and Sigma Plot. His background in quality control and regulatory compliance enables him to ensure the accuracy and reliability of diagnostic products. He is proficient in Good Laboratory Practices (GLP), Standard Operating Procedures (SOP) development, and accreditation processes for ISO 17025 and ISO 15189. Additionally, he has expertise in protein chemistry, including the development of IVD-grade recombinant proteins and monoclonal and polyclonal antibodies. His ability to integrate biotechnology with analytical techniques and computational tools makes him a well-rounded researcher dedicated to advancing biomedical science and healthcare solutions.

Awards and Honors

Dr. Dinesh Kumar has been recognized for his contributions to biomedical research and diagnostics through various awards and honors. He has received accolades for his innovative research in point-of-care diagnostics, including best oral presentation awards at international conferences. His contributions to immunoassay development and biosensor technology have earned him recognition from scientific communities and regulatory organizations. His expertise in molecular diagnostics and antimicrobial resistance has also been acknowledged through invitations to speak at prestigious global conferences. Dr. Kumar has played a key role in obtaining CE marking and ISO accreditation for various diagnostic products, demonstrating his impact on regulatory and quality assurance standards. His commitment to research excellence has been reflected in numerous publications in high-impact scientific journals. Additionally, his mentorship and training programs in diagnostics and quality control have contributed to capacity building in the healthcare sector. As a result, he has established himself as a leading expert in biomedical innovation, with a track record of excellence in research, development, and regulatory compliance. His awards and recognitions highlight his dedication to improving healthcare through cutting-edge diagnostic technologies and scientific advancements.

Conclusion

Dr. Dinesh Kumar is a highly accomplished scientist whose research has significantly advanced the field of biomedical diagnostics. His expertise in immunoassays, biosensors, and molecular diagnostics has led to the development of innovative point-of-care testing devices that address critical healthcare challenges. His extensive experience in regulatory compliance and quality control has ensured that his innovations meet international standards, making a tangible impact on the healthcare industry. His strong academic background, technical proficiency, and research skills have positioned him as a leader in diagnostic development. Dr. Kumar’s contributions to antimicrobial resistance research and biomarker detection highlight his commitment to improving early disease diagnosis and treatment outcomes. His work in nanotechnology applications, particularly in biosensor development, further enhances his eligibility for prestigious research awards. Through his dedication to innovation and excellence, Dr. Kumar continues to shape the future of biomedical research, bridging the gap between scientific discovery and clinical application to improve global healthcare.

Publication Top Notes